| Literature DB >> 33269410 |
M Aringer1, C Baerwald2, R Bergner3, M Feuchtenberger4, C Gebhardt5, M Hagen6, G Keyßer7, H-M Lorenz8, T Witte9.
Abstract
Transmitting a substantial amount of basic knowledge in Rheumatology to all medical students is essential for the future medical care of patients with rheumatic diseases for two reasons: on the one hand, future general practitioners will need to master the patterns of rheumatic diseases to recognize them fast enough in new-onset patients and to refer them in time and directly to rheumatologists. On the other hand, the shortage of rheumatologists can only then be relieved in the future when we are able to inspire enthusiasm for our specialty. Adequate rheumatological structures are established only in some of the German faculties of medicine. Structural improvements happen in small steps only but were achieved at several sites. The better the local structures, the higher the chances of committed university teachers in rheumatology to reach all medical students. Probably from 2026 onwards, the learning objectives relevant for examinations will be defined by the national competence-based catalogue of learning objectives in medicine (NKLM), which is currently in the final stages of completion together with the German Federal Institute for Medical and Pharmaceutical Examinations (IMPP). It now appears that systemic autoimmune diseases and inflammatory rheumatic diseases are adequately depicted in this catalogue. If this is achieved, students will know more about these diseases in the future and will diagnose them faster in patients. Work on the NKLM is therefore of highest importance. In addition to the work on the learning objectives, up to date learning materials are required, which have to be available throughout Germany. A Rheumatology script just finished by the committee for medical student education of the German Society of Rheumatology (DGRh) and now available on the DGRh homepage should close this gap.Entities:
Keywords: Basic education in rheumatology; Bedside teaching; Electronic learning materials; Examination contents; Learning objectives
Mesh:
Year: 2020 PMID: 33269410 PMCID: PMC7709903 DOI: 10.1007/s00393-020-00933-w
Source DB: PubMed Journal: Z Rheumatol ISSN: 0340-1855 Impact factor: 1.372
| Prävalenz | Lebensgefahr | Schaden | Diagnose zeitkritisch | |
|---|---|---|---|---|
| Rheumatoide Arthritis | Ca. 1 % | Erst spät | Hoch | Ja (6 Wochen) |
| Spondylarthritiden | Ca. 1 % | Erst spät | Hoch | Ja (Monate) |
| Kollagenosen | Ca. 2 ‰ | Potenziell | Hoch | Ja (Wochen) |
| Vaskulitiden | Ca. 0,5 ‰ | Ja | Hoch | Ja (Tage) |
| Riesenzellarteriitis und PMR | Ca. 1 ‰ | Potenziell | Hoch | Ja (Tage) |
| Kristallarthritiden | 5 % | Erst spät | Mäßig | Bedingt (Monate) |
PMR Polymyalgia rheumatica
| 21.1.1.23 | Vaskulitiden/DD Vaskulitis |
| 21.1.1.27 | Primäres und sekundäres Raynaud-Syndrom |
| 21.1.2.3 | Gicht und Chondrokalzinose |
| 21.1.2.10 | Osteoporose |
| 21.1.2.29 | Polymyositis/Dermatomyositis |
| 21.1.2.31 | Arthrose |
| 21.1.2.33 | Septische Arthritis/reaktive Arthritis |
| 21.1.2.38 | Seropositive und seronegative rheumatoide Arthritis |
| 21.1.2.39 | Morbus Bechterew/axiale Spondylarthritis |
| 21.1.2.40 | Borreliose |
| 21.1.2.41 | Sonstige Arthritiden/DD Arthritis |
| 21.1.2.42 | Fibromyalgiesyndrom |
| 21.1.5.15 | Goodpasture-Syndrom |
| 21.1.5.17 | Antiphospholipidsyndrom |
| 21.1.5.18 | Sjögren-Syndrom |
| 21.1.8.22 | Lupus erythematodes |
| 21.1.8.24 | Psoriasis, Psoriasisarthritis |
| 21.1.8.44 | Systemische Sklerose (Sklerodermie) |
DD Differenzialdiagnose
| IMPP | Institut für medizinische und pharmazeutische Prüfungsfragen | Bundesinstitut mit Verantwortung für die Staatsprüfungen |
| LOOOP | Learning Opportunities, Objectives and Outcomes Platform | Charité-Forschungsnetzwerk für Curriculum-Entwicklung und Curriculum-Mapping |
| MFT | Medizinischer Fakultätentag | Dachverband der 38 medizinischen Fakultäten in Deutschland |
| NKLM | Nationaler Kompetenzbasierter Lernzielkatalog Medizin | Neuer, deutschlandweit verbindlicher Lernzielkatalog für die Medizin |
| Ordentliche Professuren | APL-Professur | Andere | |
|---|---|---|---|
| Unabhängig | Abhängig | ||
| Berlin Charité | Berlin Charité CBF | Essen (Lehr-KH) | Aachen |
| Bochum | Dresden | Halle | Augsburg |
| Düsseldorf | Frankfurt | Jena | Bonn |
| Erlangen | Hamburg | Magdeburg (Lehr-KH) | Göttingen |
| Freiburg | Heidelberg | Mannheim (Lehr-KH) | Greifswald |
| Gießen | Kiel | Marburg (Lehr-KH) | Homburg |
| Hannover | Leipzig | Tübingen | Köln |
| Lübeck | Mainz | – | München TU |
| – | München LMU | – | Rostock |
| – | Münster | – | Ulm |
| – | Würzburg | – | – |
| – | Regensburg | – | – |
APL außerplanmäßig, KH Krankenhaus
| VL | Thema | Erkrankungen | Medikamente |
|---|---|---|---|
| 1 | Rheumatoide Arthritis | RA, Still (AOSD) | DMARDs, Biologika |
| 2 | Spondylarthritiden | AS, PsA, CED-Arthritis, ReA | NSAR/Coxibe |
| 3 | Akute Arthritis | Gicht, CPPD-Erkrankung, septische Arthritis, Borreliose | Harnsäuresenker, Colchicin |
| 4 | Kollagenosen | SLE, SjS, SSc, PM/DM, MCTD | HCQ, Aza, MMF, BEL |
| 5 | Arteriitiden und Vaskulitiden | GCA, PMR | Glukokortikoide |
| 6 | Osteoarthrose und FMS | Osteoarthrose, Spondylose, Spondylarthrose, FMS | Physiotherapie, Trizyklika, SNRI |
VL Vorlesung, RA rheumatoide Arthritis, AOSD adulter Morbus Still, DMARDs „disease-modifying anti-rheumatic drug“, AS ankylosierende Spondylitis, PsA Psoriasisarthritis, CED chronisch entzündliche Darmerkrankungen, ReA reaktive Arthritis, NSAR nichtsteroidale Antirheumatika, CPPD Chondrokalzinose, Pyrophosphatarthropathie, SLE systemischer Lupus erythematodes, SjS Sjögren-Syndrom, SSc systemische Sklerose, PM/DM Polymyalgia rheumatica/Dermatomyositis, MCTD „mixed connective tissue disease“, HCQ Hydroxychloroquin, Aza Azathioprin, MMF Mycophenolat-Mofetil, BEL Belimumab, GCA Riesenzellarteriitis, PMR Polymyalgia rheumatica, FMS Fibromyalgiesyndrom, SNRI Serotonin-Noradrenalin-Wiederaufnahme-Inhibitoren